These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 8411111

  • 1. Long-term protection of macaques against high-dose type D retrovirus challenge after immunization with recombinant vaccinia virus expressing envelope glycoproteins.
    Benveniste RE, Kuller L, Roodman ST, Hu SL, Morton WR.
    J Med Primatol; 1993; 22(2-3):74-9. PubMed ID: 8411111
    [Abstract] [Full Text] [Related]

  • 2. Protection of vaccinia-primed macaques against SIVmne infection by combination immunization with recombinant vaccinia virus and SIVmne gp160.
    Hu SL, Stallard V, Abrams K, Barber GN, Kuller L, Langlois AJ, Morton WR, Benveniste RE.
    J Med Primatol; 1993; 22(2-3):92-9. PubMed ID: 8411113
    [Abstract] [Full Text] [Related]

  • 3. Protection of macaques against simian AIDS by immunization with a recombinant vaccinia virus expressing the envelope glycoproteins of simian type D retrovirus.
    Hu SL, Zarling JM, Chinn J, Travis BM, Moran PA, Sias J, Kuller L, Morton WR, Heidecker G, Benveniste RE.
    Proc Natl Acad Sci U S A; 1989 Sep; 86(18):7213-7. PubMed ID: 2550935
    [Abstract] [Full Text] [Related]

  • 4. Protection of macaques against infection with simian type D retrovirus (SRV-1) by immunization with recombinant vaccinia virus expressing the envelope glycoproteins of either SRV-1 or Mason-Pfizer monkey virus (SRV-3).
    Brody BA, Hunter E, Kluge JD, Lasarow R, Gardner M, Marx PA.
    J Virol; 1992 Jun; 66(6):3950-4. PubMed ID: 1316495
    [Abstract] [Full Text] [Related]

  • 5. Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus.
    Martinon F, Brochard P, Ripaux M, Delache B, Aurégan G, Vaslin B, Le Grand R.
    Vaccine; 2008 Jan 24; 26(4):532-45. PubMed ID: 18093703
    [Abstract] [Full Text] [Related]

  • 6. Type D SRV-2 virus-specific CD8+ and CD4- CD8- T cells that regulate virus-induced T cell proliferation in Celebes macaques.
    Malley A, Pangares N, Mayo SK, Zeleny-Pooley M, Torres JV, Benjamin E, Axthelm MK.
    J Med Primatol; 1993 Jan 24; 22(2-3):80-5. PubMed ID: 7692057
    [Abstract] [Full Text] [Related]

  • 7. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
    Kumar A, Lifson JD, Li Z, Jia F, Mukherjee S, Adany I, Liu Z, Piatak M, Sheffer D, McClure HM, Narayan O.
    Virology; 2001 Jan 05; 279(1):241-56. PubMed ID: 11145906
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Reduced virus load in rhesus macaques immunized with recombinant gp160 and challenged with simian immunodeficiency virus.
    Ahmad S, Lohman B, Marthas M, Giavedoni L, el-Amad Z, Haigwood NL, Scandella CJ, Gardner MB, Luciw PA, Yilma T.
    AIDS Res Hum Retroviruses; 1994 Feb 05; 10(2):195-204. PubMed ID: 8198872
    [Abstract] [Full Text] [Related]

  • 13. Screening for simian type-D retrovirus infection in macaques, using nested polymerase chain reaction.
    Lerche NW, Cotterman RF, Dobson MD, Yee JL, Rosenthal AN, Heneine WM.
    Lab Anim Sci; 1997 Jun 05; 47(3):263-8. PubMed ID: 9241627
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3.
    Kent SJ, Dale CJ, Ranasinghe C, Stratov I, De Rose R, Chea S, Montefiori DC, Thomson S, Ramshaw IA, Coupar BE, Boyle DB, Law M, Wilson KM, Ramsay AJ.
    Vaccine; 2005 Oct 10; 23(42):5009-21. PubMed ID: 15985317
    [Abstract] [Full Text] [Related]

  • 16. Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques.
    Miyake A, Akagi T, Enose Y, Ueno M, Kawamura M, Horiuchi R, Hiraishi K, Adachi M, Serizawa T, Narayan O, Akashi M, Baba M, Hayami M.
    J Med Virol; 2004 Jul 10; 73(3):368-77. PubMed ID: 15170630
    [Abstract] [Full Text] [Related]

  • 17. Subunit vaccine protects Macaca nemestrina (pig-tailed macaque) against simian T-cell lymphotropic virus type I challenge.
    Dezzutti CS, Frazier DE, Huff LY, Stromberg PC, Olsen RG.
    Cancer Res; 1990 Sep 01; 50(17 Suppl):5687S-5691S. PubMed ID: 2167165
    [Abstract] [Full Text] [Related]

  • 18. Recombinant Mycobacterium bovis BCG vector system expressing SIV Gag protein stably and persistently induces antigen-specific humoral immune response concomitant with IFN gamma response, even at three years after immunization.
    Kawahara M.
    Clin Immunol; 2008 Dec 01; 129(3):492-8. PubMed ID: 18849196
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.